← Back to screener

Nuvation Bio Inc. NUVB

Rank #2304 · NYSE · $1.7B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
25.2
P/E
-2.9
P/B
2.74
ROE
-93.9%
Op. Margin
-7527.3%
Debt Ratio
13%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E -2.9x, P/B 2.74x. Ranks in the top 70% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -93.9%. Ranks in the top 96% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 13%. Ranks in the top 10% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2020–––$0.0B––
2021–$-0.0B$-0.0B$0.1B–6
2022–$-0.1B$-0.1B$0.2B–14
2023–$-0.1B$-0.1B$0.7B–2
2024$0.0B$-0.1B$-0.1B$0.7B–2
2025$0.0B$-0.6B$-0.6B$0.6B-7527.313

← See the full screener